NASDAQ:WMGI - Wright Medical Group Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$28.39 -0.04 (-0.14 %)
(As of 10/17/2018 11:37 AM ET)
Previous Close$28.43
Today's Range$28.11 - $28.44
52-Week Range$19.01 - $29.50
Volume5,492 shs
Average Volume1.22 million shs
Market Capitalization$3.10 billion
P/E Ratio-128.64
Dividend YieldN/A

Analyst Ratings

Wright Medical Group (NASDAQ:WMGI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
13 Wall Street analysts have issued ratings and price targets for Wright Medical Group in the last 12 months. Their average twelve-month price target is $31.0833, suggesting that the stock has a possible upside of 9.49%. The high price target for WMGI is $35.00 and the low price target for WMGI is $25.00. There are currently 1 hold rating and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.922.922.732.78
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $31.0833$31.0833$29.6667$29.3750
Price Target Upside: 9.49% upside9.91% upside14.32% upside43.71% upside

Wright Medical Group (NASDAQ:WMGI) Consensus Price Target History

Price Target History for Wright Medical Group (NASDAQ:WMGI)

Wright Medical Group (NASDAQ:WMGI) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/29/2018BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$28.00 ➝ $31.00MediumView Rating Details
8/28/2018Needham & Company LLCUpgradeHold ➝ Buy$30.00HighView Rating Details
8/21/2018Stifel NicolausInitiated CoverageBuy$34.00HighView Rating Details
8/9/2018Piper Jaffray CompaniesBoost Price TargetOverweight$32.00HighView Rating Details
8/9/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$28.00 ➝ $32.00HighView Rating Details
8/9/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$28.00 ➝ $30.00HighView Rating Details
8/9/2018Bank of AmericaUpgradeNeutral ➝ Buy$28.00 ➝ $34.00LowView Rating Details
8/9/2018OppenheimerSet Price TargetHold$28.00HighView Rating Details
8/9/2018Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$30.00 ➝ $35.00HighView Rating Details
6/21/2018Leerink SwannBoost Price TargetOutperform ➝ Outperform$27.00 ➝ $32.00HighView Rating Details
6/13/2018GuggenheimUpgradeNeutral ➝ BuyHighView Rating Details
2/28/2018BarclaysReiterated RatingOverweight ➝ Overweight$27.00 ➝ $25.00LowView Rating Details
11/2/2017Royal Bank of CanadaReiterated RatingBuy$30.00N/AView Rating Details
3/21/2017Northcoast ResearchUpgradeNeutral ➝ Buy$36.00MediumView Rating Details
(Data available from 10/17/2016 forward)
This page was last updated on 10/17/2018 by Staff

Featured Article: What is the balance sheet?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel